Source: FDA, document on file. FDA released the Form 483 itself. The document linked above is our copy of FDA's file, stored by us so the link cannot break, and FDA's own copy is linked beside it. To check it, open FDA's record for this establishment on FDA's Data Dashboard, listed under FEI 2220525.
Observations3
Issue DateJune 12, 2024
StatusNo Warning Letter
Establishment TypeOutsourcing Facility
Related Inspections10
Establishment Details
Firm
Hikma Pharmaceuticals USA Inc.
Location
Cherry Hill, New Jersey, United States
FEI Number
2220525
Establishment Type
Outsourcing Facility
Product Type
Outsourcing Facility
Issue Date
June 12, 2024
Country
United States
Inspection History, 2014 to 2026
NAI7
VAI3
NAI means No Action Indicated. VAI means Voluntary Action Indicated.
Talk to a Specialist